Assignee
UROGEN PHARMA LTD
IL·12 granted patents·15 pending applications·38 citations·filing 2013–2025
Top patents by PatentIndex Score
27 records- 0191US10471150B2Material and method for treating internal cavitiesUROGEN PHARMA LTD·Filed 2013·Granted Nov 12, 2019·9 cites·13 claims
- 0289US9950069B2Material and method for treating internal cavitiesUROGEN PHARMA LTD·Filed 2016·Granted Apr 24, 2018·10 cites·30 claims
- 0387US12268745B2Material and method for treating internal cavitiesUROGEN PHARMA LTD·Filed 2024·Granted Apr 8, 2025·0 cites·8 claims
- 0487US10039832B2Material and method for treating internal cavitiesUROGEN PHARMA LTD·Filed 2015·Granted Aug 7, 2018·7 cites·23 claims
- 0586US10758482B2Immunomodulating treatments of body cavitiesUROGEN PHARMA LTD·Filed 2019·Granted Sep 1, 2020·3 cites·15 claims
- 0685US9540407B2Phospholipid drug analogsUROGEN PHARMA LTD·Filed 2015·Granted Jan 10, 2017·5 cites·18 claims
- 0782US2023241220A1Material and method for treating internal cavitiesUROGEN PHARMA LTD·Filed 2023·Application pending·0 cites
- 0882US2023241221A1Material and method for treating internal cavitiesUROGEN PHARMA LTD·Filed 2023·Application pending·0 cites
- 0982US2023233685A1Material and method for treating internal cavitiesUROGEN PHARMA LTD·Filed 2023·Application pending·0 cites
- 1079US12263245B2Immunomodulating treatments of body cavitiesUROGEN PHARMA LTD·Filed 2024·Granted Apr 1, 2025·0 cites·21 claims
- 1178US12440568B2Material and method for treating internal cavitiesUROGEN PHARMA LTD·Filed 2025·Granted Oct 14, 2025·0 cites·10 claims
- 1278US2022118096A1Material and method for treating internal cavitiesUROGEN PHARMA LTD·Filed 2021·Application pending·0 cites
- 1377US10994109B2Connectable catheterUROGEN PHARMA LTD·Filed 2015·Granted May 4, 2021·4 cites·11 claims
- 1474US2020114008A1Material and method for treating internal cavitiesUROGEN PHARMA LTD·Filed 2019·Application pending·0 cites
- 1571US12171747B2Material and method for treating cancerUROGEN PHARMA LTD·Filed 2023·Granted Dec 24, 2024·0 cites·9 claims
- 1671US2023218521A1Immunomodulating treatments of body cavitiesUROGEN PHARMA LTD·Filed 2023·Application pending·0 cites
- 1768US2025032409A1Treatment of low-grade intermediate-risk non-muscle-invasive bladder cancer with a thermally gelling pharmaceutical composition containing mitomycinUROGEN PHARMA LTD·Filed 2024·Application pending·0 cites
- 1864US12336979B2Material and method for treating cancerUROGEN PHARMA LTD·Filed 2021·Granted Jun 24, 2025·0 cites·6 claims
- 1963US2025221929A1Immunomodulating treatments of body cavitiesUROGEN PHARMA LTD·Filed 2025·Application pending·0 cites
- 2062US2024100019A1Compositions comprising a thermoreversible hydrogel, and having an extended in-use periodUROGEN PHARMA LTD·Filed 2023·Application pending·0 cites
- 2161US2020397695A1Immunomodulating treatments of body cavitiesUROGEN PHARMA LTD·Filed 2020·Application pending·0 cites
- 2257US2020276183A1Pharmaceutical compositions comprising imiquimod for use in the treatment of carcinoma in situ of the bladderUROGEN PHARMA LTD·Filed 2019·Application pending·0 cites
- 2353US11576744B2Thermosensitive bio-adhesive hydrogel for removal of ureteral and renal stonesUROGEN PHARMA LTD·Filed 2022·Granted Feb 14, 2023·0 cites·20 claims
- 2453US2017266297A1Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administrationUROGEN PHARMA LTD·Filed 2017·Application pending·0 cites
- 2552US2017143833A1Production of thermoreversible hydrogels for therapeutic applicationsUROGEN PHARMA LTD·Filed 2017·Application pending·0 cites
- 2637US2019000667A1Connectable catheter systemUROGEN PHARMA LTD·Filed 2016·Application pending·0 cites
- 2734US2016331743A1Pharmaceutical compositions comprising imiquimod for use in the treatment of carcinoma in situ of the bladderUROGEN PHARMA LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when UROGEN PHARMA LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →